SLU Therapeutics Intellectual Property Portfolio
Popular Searches
00-011 Factor IXa: Factor VIIIa interaction and methods therefore
01-002 Proteins with an attached short peptide of acidic amino acids
03-013 Method of manufacturing a stellate cell death factor
03-019 Methods and compositions for vaccination
06-002 Polypeptide fragment of constitutive coactivator of PPARgamma
06-013 Chimeral polypeptide composition for cross-placenta delivery
06-030 Methods and compositions for activated Protein C mutant with reduced anticoagulant properties
06-047 Compositions and methods for treating immune system mediated diseases
10-006 Method and composition for the management of cardiovascular disease with oligonucleotides
10-007 Delivery of therapeutic agents to the bone
10-010 Virus-expressing host costimulation molecules
10-018 Peptides for inducing heterosubtypic influenza T cell responses
10-021 Method of treating chronic pain
10-032 Expression of anticoagulant thrombin mutants in Escherichia coli
10-036 Prenatal enzyme replacement therapy
10-038 Compositions and methods of treating disease by stimulating ATP release by red blood cells
11-002 Use of adenosine A3 receptor agonists for treatment of neuropathic pain
11-008 Compositions/therapy targeting neuromuscular junction
11-015 Adenovirus E1A fragments for use in anti-cancer therapies
11-017 Methods for treating inflammation
11-027 Use of indomethacin-based drugs to treat Cornelia de Lange Syndrome
11-031.1 Auto-activation of trypsin-like proteases
12-013 Suppression of bone loss by introducing FOXP3+ CD8 T-cells
12-014 Aminohydantoin Compounds as Antimalarial Agents
13-023 Method for reducing incidence of fibrosis caused by peritoneal dialysis
14-002 Antibody-based therapeutics for the treatment of diabetes complications
14-011 Suppression of bone loss by introducing FoxP3+CD8 T-cells
Ready to take the next step? Request more information, schedule a visit or apply for admission.